Skip to main content

Animations

MJFF Publications

4411 - 4420 of 9145 Results
Title
Year
  • Year
  • 2018
  • 2021
  • 2015
  • 2021
  • 2025
  • 2010
  • 2012
  • 2018
  • 2020
  • 2022
  • Phosphorylated α‐synuclein in the retina is a biomarker of Parkinson's disease pathology severity
    2018
    Summary Details
    RESTRICTED
    Title: Phosphorylated α‐synuclein in the retina is a biomarker of Parkinson's disease pathology severity
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27392
    Citation Count: 165
  • Summary Details
    OPEN
    Title: The TCR repertoire of α-synuclein-specific T cells in Parkinson’s disease is surprisingly diverse
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-020-79726-9
    Citation Count: 37
  • Summary Details
    RESTRICTED
    Title: Striatal and Cortical β‐Amyloidopathy and Cognition in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26369
    Citation Count: 62
  • Summary Details
    OPEN
    Title: Retrospective motion artifact correction of structural MRI images using deep learning improves the quality of cortical surface reconstructions
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2021.117756
    Citation Count: 98
  • Summary Details
    OPEN
    Title: Subthalamic deep brain stimulation alleviates the gait sequence effect and freezing of gait in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108062
    Citation Count: 1
  • LRRK2 variation and Parkinson's disease in African Americans
    2010
    Summary Details
    RESTRICTED
    Title: LRRK2 variation and Parkinson's disease in African Americans
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.23163
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2012.03.038
    Citation Count: 41
  • At last, a randomised controlled trial of apomorphine infusion
    2018
    Summary Details
    RESTRICTED
    Title: At last, a randomised controlled trial of apomorphine infusion
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30284-9
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Prevalence of REM sleep behavior disorder in Sun City, Arizona
    Journal Name: Heliyon
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.heliyon.2019.e03140
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Differences in Sex‐Specific Frequency of Glucocerebrosidase Variant Carriers and Familial Parkinsonism
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29197
    Citation Count: 25
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.